Larson Financial Group’s Anixa Biosciences ANIX Stock Holding History

Larson Financial Group’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4K	Hold	500	–	–	﹤0.01%	3214
2026 Q1	$1.29K	Hold	500	–	–	﹤0.01%	3083
2025 Q4	$1.56K	Hold	500	–	–	﹤0.01%	2831
2025 Q3	$1.65K	Hold	500	–	–	﹤0.01%	2777
2025 Q2	$1.65K	Hold	500	–	–	﹤0.01%	2485
2025 Q1	$1.43K	Hold	500	–	–	﹤0.01%	2277
2024 Q4	$1.16K	Hold	500	–	–	﹤0.01%	2004
2024 Q3	$1.57K	Hold	500	–	–	﹤0.01%	1900
2024 Q2	$1.1K	Hold	500	–	–	﹤0.01%	1689
2024 Q1	$1.56K	Sell	500 -25	-5%	-$100	﹤0.01%	1389
2023 Q4	$2.04K	Hold	525	–	–	﹤0.01%	1367
2023 Q3	$1.72K	Hold	525	–	–	﹤0.01%	1387
2023 Q2	$1.68K	Hold	525	–	–	﹤0.01%	1293
2023 Q1	$2.26K	Hold	525	–	–	﹤0.01%	1226
2022 Q4	$2.23K	Hold	525	–	–	﹤0.01%	1176
2022 Q3	$3K	Hold	525	–	–	﹤0.01%	1026
2022 Q2	$2K	Buy	525 +25	+5%	+$79	﹤0.01%	1002
2022 Q1	$1K	Buy	+500	New	+$1.47K	﹤0.01%	949

Other funds holding ANIX

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Larson Financial Group's ANIX Position: Q2 2026 in Review

Larson Financial Group held its Anixa Biosciences (ANIX) position steady in Q2 2026 at 500 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3214.

Larson Financial Group first reported a position in ANIX in Q1 2022 and has held it in 18 quarters since. The position peaked at $3K in Q3 2022. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

Larson Financial Group held 500 shares of Anixa Biosciences worth $1.4K as of Q2 2026.
Larson Financial Group left its Anixa Biosciences share count unchanged in Q2 2026.
Anixa Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3214 holding.
Larson Financial Group first reported a position in Anixa Biosciences in Q1 2022 and has held it in 18 quarters since.
Larson Financial Group's Anixa Biosciences position peaked at $3K in Q3 2022.
62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.